ANTIHAEMORROID, ointment, 20-30g, tube
STD
DEXTANTH1O2
Valid Article
Account code:
60000
HS Code:
300490
Last Updated on:
20/11/2024, 22:15:01
Former
Code(s):
DEXTANTH1C3 DEXTZYN1012
13.3 - Anti-inflammatory and antipruritic medicines
Classification of the medicines in groups and subgroups according to their therapeutic use.
The classification used by MSF is based on the WHO Model List of Essential Medicines.
C05AX
Anatomical Therapeutic Chemical Classification according to WHOCC
OC subscriptions: included in supply or field order tools (e.g. UniField)
|
|
SC subscriptions: included in supply or field tools
|
|
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)
|
|
ANTIHAEMORROID ointment
- Not in the WHO list of Essential Medicines 2023
Therapeutic Action
Combination of lidocaine (local anaesthetic) and zinc oxide (skin protector and mild astringent)
Indications
Painful and pruriginous anal manifestations, especially during the haemorrhoidal crisis
Instructions for use
Rectal use
Apply the product around the anus with a finger or inside the anus with the cannula.
Ideally, the product should contain lidocaine and zinc oxide. Other suitable ingredients include allantoin, calamine, kaolin, zinc sulfate.
Avoid preparations containing balsam Peru or bismuth salts.
Ointment is the preferred form over cream.
Storage
- Below 25ºC
- Tightly close the tube after each use to prevent contamination.